Bill > S0862

This bill modifies Florida's Prescription Drug Monitoring Program, a system managed by the Department of Health (DOH) to track controlled substance prescriptions. Key changes include requiring the DOH to establish a user agreement by rule for accessing the system, and allowing the DOH to share non-personally identifiable information with law enforcement agencies if the program manager identifies a concerning pattern of drug use. The bill also repeals provisions related to a direct-support organization that previously funded the program, shifting funding responsibilities to the Medical Quality Assurance Trust Fund and allowing for federal or private grants, but prohibiting funds from prescription drug manufacturers. Additionally, the bill clarifies definitions, reporting requirements, and exemptions for dispensing controlled substances, and strengthens provisions regarding the verification of a person's identity before dispensing a controlled substance, unless in specific institutional settings.